Literature DB >> 23546708

Activated partial thromboplastin time.

Vera Ignjatovic1.   

Abstract

Activated partial thromboplastin time (APTT) is a commonly used coagulation assay that is easy to perform, is affordable, and is therefore performed in most coagulation laboratories, both clinical and research, worldwide. The APTT is based on the principle that in citrated plasma, the addition of a platelet substitute, factor XII activator, and CaCl2 allows for formation of a stable clot. The time required for the formation of a stable clot is recorded in seconds and represents the actual APTT result.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23546708     DOI: 10.1007/978-1-62703-339-8_8

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  5 in total

Review 1.  An introduction to point-of-care testing in extracorporeal circulation and LVADs.

Authors:  Rachel Sara Bercovitz
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

2.  Prolonged activated partial thromboplastin time predicts poor short-term prognosis in patients with acute pancreatitis: A retrospective cohort study.

Authors:  Yuping Yang; Shenshen Du; Weinan Yuan; Yanqi Kou; Biao Nie
Journal:  Clin Transl Sci       Date:  2022-08-07       Impact factor: 4.438

3.  The Prevalence of Coagulopathy and Associated Factors Among Adult Type II Diabetes Mellitus Patients Attending the University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia.

Authors:  Fasil Getu; Melak Aynalem; Segenet Bizuneh; Bamlaku Enawgaw
Journal:  Diabetes Metab Syndr Obes       Date:  2022-02-24       Impact factor: 3.168

4.  First-In-Human Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of SHR2285, a Small-Molecule Factor XIa Inhibitor in Healthy Subjects.

Authors:  Rui Chen; Xiaoduo Guan; Pei Hu; Yanli Dong; Yi Zhu; Tengfei Zhang; Jianjun Zou; Shuyang Zhang
Journal:  Front Pharmacol       Date:  2022-02-10       Impact factor: 5.810

5.  System performance evaluation of the cobas t 711 and cobas t 511 coagulation analyzers in routine laboratory settings.

Authors:  Steve Kitchen; Moniek de Maat; Michael Nagler; Robert Jones; Anna Lowe; John Burden; Kai Groneberg; Gergely Rozsnyai
Journal:  Blood Coagul Fibrinolysis       Date:  2020-10       Impact factor: 1.061

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.